Large-scale breast cancer screening trial achieves enrollment goal, paving the way for precision approach to screening

by

The Tomosynthesis Mammographic Imaging Screening Trial (TMIST) has reached its enrollment goal of 108,508 women, as announced today by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN).

Leave A Comment

Your email address will not be published. Required fields are marked *